March 2018 Update
The March 2018 revision of the Cochrane Priority Reviews List includes new titles from the Cochrane Effective Practice & Organisation of Care, Oral Health; and Pregnancy & Childbirth Groups.
The following three titles on the list are open to new authors - please note restrictions:
- Antioxidants for respiratory function in Duchenne muscular dystrophy – Neuromuscular Disease (Open only to authors with Duchenne muscular dystrophy research and clinical practice expertise)
- Particle versus photons for the treatment of chordoma – Neuro-oncology/Gynaecological Cancer
- Prediction models for adjuvant chemotherapy or radiotherapy for women with endometrial cancer – Neuro-oncology/Gynaecological Cancer (Prognostic methodology expertise preferred)
Cochrane-wide prioritisation remains an important project, with almost 230 priority reviews or updates published since the project began in January 2015.
Please be aware that all titles in the priority list have author teams in place, except for those mentioned above. If you are interested in one of these open titles please contact the relevant Cochrane Review Group before submitting a review proposal.
If you would like to contribute more generally to Cochrane’s prioritisation work, please contact Ruth Foxlee (rfoxlee@cochrane.org).
Download the Cochrane Priority Review list for 2018 (March revision)
Ruth Foxlee, Information Specialist, Cochrane Editorial Unit,
Tuesday, April 4, 2018